Charles Williams
Förmögenhet: 401 579 $ per 2026-08-31
Förmögenhet: 401 579 $ per 2026-08-31
Charles Williams is Secretary & Chief Operating Officer at Surrozen, Inc. since 2025.
Formerly, Mr. Williams was Head-Corporate Development at Jazz Pharmaceuticals Plc from 2013 to 2020 and Director-Corporate & Business Development at MAP Pharmaceuticals LLC from 2008 to 2013.
Mr. Williams completed undergraduate education at Cornell University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SURROZEN INC 0,16 % | 2026-06-15 | 18 237 ( 0,16 % ) | 401 579 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| SURROZEN, INC. | Verksamhetschef | 2024-02-01 |
| Företag | Position | Slut |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Företagsledare/Principal | 2020-11-01 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Företagsledare/Principal | 2013-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Surrozen, Inc.
Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån